Target intelligence / Profile preview

Long intergenic non-protein coding RNA 3032 (LINC03032)

Target
LINC03032
Molecular classification
Other, Non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 3032 (LINC03032) is a long intergenic non-coding RNA (lincRNA) gene, meaning it codes for an RNA molecule longer than 200 nucleotides that does not overlap with any known protein-coding gene[1][5][3]. LincRNAs such as LINC03032 are distinguished from other long non-coding RNAs by their exclusively intergenic transcription origin and their lack of protein-coding potential[3]. Functionally, while many lincRNAs have been shown to participate in chromatin modification, regulation of gene expression in *cis* or *trans*, and organization of nuclear architecture, specific functional studies or disease associations for LINC03032 remain lacking. Its role is considered regulatory and non-protein coding, potentially fine-tuning the expression of nearby genes with high tissue specificity, but without evidence that it acts as a direct therapeutic target, enzyme, transporter, receptor, or other well-characterized druggable molecule[3]. No clinical biomarkers, interacting drugs, or safety concerns are currently associated with LINC03032.

Other names
LINC03032
02

Biological functions

Regulation of transcriptionChromatin remodelingGenome architecture organizationRNA stabilizationPossibly enhancer-associated regulatory functions
03

Disease associations

Other (Potential but not documented for LINC03032 specifically; some lincRNAs are involved in cancer and other diseases, but no disease association specifically documented for LINC03032 as of current knowledge)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 3032 (LINC03032).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 3032 (LINC03032).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call